K Kashihara, T Ebara, M Yamamoto, T Ogawa, T Harada, S Otsuki
{"title":"麻酸钙对抗精神病药致迟发性运动障碍的临床及生化影响。","authors":"K Kashihara, T Ebara, M Yamamoto, T Ogawa, T Harada, S Otsuki","doi":"10.1111/j.1440-1819.1985.tb02898.x","DOIUrl":null,"url":null,"abstract":"<p><p>Calcium-hopantenate (HOPA), a derivative of GABA, was administered to 9 psychiatric patients with neuroleptics-induced tardive dyskinesia. In a clinical study, involuntary movements have improved significantly after a 4-8-week medication. Although there was no correlation between the cerebrospinal fluid (CSF) levels of HOPA, GABA, HVA or clinical response, the CSF HOPA levels significantly correlated with changes in the CSF GABA levels. These results suggest that HOPA alleviates the symptoms of tardive dyskinesia being mediated by the central GABAergic mechanisms.</p>","PeriodicalId":75857,"journal":{"name":"Folia psychiatrica et neurologica japonica","volume":"39 2","pages":"147-53"},"PeriodicalIF":0.0000,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1440-1819.1985.tb02898.x","citationCount":"0","resultStr":"{\"title\":\"Clinical and biochemical effects of calcium-hopantenate on neuroleptics-induced tardive dyskinesia.\",\"authors\":\"K Kashihara, T Ebara, M Yamamoto, T Ogawa, T Harada, S Otsuki\",\"doi\":\"10.1111/j.1440-1819.1985.tb02898.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Calcium-hopantenate (HOPA), a derivative of GABA, was administered to 9 psychiatric patients with neuroleptics-induced tardive dyskinesia. In a clinical study, involuntary movements have improved significantly after a 4-8-week medication. Although there was no correlation between the cerebrospinal fluid (CSF) levels of HOPA, GABA, HVA or clinical response, the CSF HOPA levels significantly correlated with changes in the CSF GABA levels. These results suggest that HOPA alleviates the symptoms of tardive dyskinesia being mediated by the central GABAergic mechanisms.</p>\",\"PeriodicalId\":75857,\"journal\":{\"name\":\"Folia psychiatrica et neurologica japonica\",\"volume\":\"39 2\",\"pages\":\"147-53\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1985-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/j.1440-1819.1985.tb02898.x\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Folia psychiatrica et neurologica japonica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/j.1440-1819.1985.tb02898.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Folia psychiatrica et neurologica japonica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/j.1440-1819.1985.tb02898.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Clinical and biochemical effects of calcium-hopantenate on neuroleptics-induced tardive dyskinesia.
Calcium-hopantenate (HOPA), a derivative of GABA, was administered to 9 psychiatric patients with neuroleptics-induced tardive dyskinesia. In a clinical study, involuntary movements have improved significantly after a 4-8-week medication. Although there was no correlation between the cerebrospinal fluid (CSF) levels of HOPA, GABA, HVA or clinical response, the CSF HOPA levels significantly correlated with changes in the CSF GABA levels. These results suggest that HOPA alleviates the symptoms of tardive dyskinesia being mediated by the central GABAergic mechanisms.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
